Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial

BACKGROUND: Myocardial infarction causes irreversible loss of cardiomyocytes and may lead to loss of ventricular function, morbidity and mortality. Infarct size is a major prognostic factor and reduction of infarct size has therefore been an important objective of strategies to improve outcomes. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Scholte, Martijn, Timmers, Leo, Bernink, Flip JP, Denham, Robert N, Beek, Aernout M, Kamp, Otto, Diamant, Michaela, Horrevoets, Anton JG, Niessen, Hans WM, Chen, Weena JY, van Rossum, Albert C, van Royen, Niels, Doevendans, Pieter A, Appelman, Yolande
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235971/
https://www.ncbi.nlm.nih.gov/pubmed/22067476
http://dx.doi.org/10.1186/1745-6215-12-240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235971/
https://www.ncbi.nlm.nih.gov/pubmed/22067476
http://dx.doi.org/10.1186/1745-6215-12-240

Ejemplares similares